MM+M Podcast 8.12.21: Agile Therapeutics’ Amy Welsh

Amy Welsh, Agile Therapeutics VP of marketing, discusses some of the ways she’s helping hormone patch Twirla break through in the birth control market, including advertising on dating app Tinder.

MM+M Staff

August 12, 2021

10:49 am

Just how easy is it to launch a drug in the not-quite-post-pandemic pharma landscape? Amy Welsh, Agile Therapeutics VP of marketing, discusses some of the ways she’s helping hormone patch Twirla, which launched in December, to break through in the $7 billion birth control market, including advertising to Millennial and Gen-Z women on dating app Tinder.

From Our Partners

Mapping the identity experience in digital health communications

Partner Content

Mapping the identity experience in digital health communications

How IX offers greater nuance in engaging with audiences.

The state of DE&I: Moving the needle from commitment to progress

Partner Content

The state of DE&I: Moving the needle from commitment to progress

Employees and consumers alike expect companies to take meaningful steps toward creating a more equitable and inclusive future. As shown by the findings from MM+M’s 2022 Diversity Survey, conducted in partnership with IPG Health, progress has been made but we still have a long way to go in the healthcare industry.

How to keep digital pharma marketing relevant in the times of global crises

Partner Content

How to keep digital pharma marketing relevant in the times of global crises

Nataliya Andreychuk, CEO of Viseven, discusses digital marketing trends and more during her chat with Marc Iskowitz, editor-at-large, MM+M.

Why marketers must make the switch to privacy-safe real-world data for targeting

Partner Content

Why marketers must make the switch to privacy-safe real-world data for targeting

Developing more precise and brand-exclusive patient segments with higher audience quality.